The Pathological and Physiological Roles of IL-6 Amplifier Activation

Overview

Journal Int J Biol Sci

Specialty Biology

Date 2012 Nov 9

PMID 23136555

Citations 29

Authors

Masaaki Murakami

Toshio Hirano

Affiliations

Soon will be listed here.

Abstract

The NFκB-triggered positive feedback loop for IL-6 signaling in type 1 collagen+ non-immune cells (IL-6 amplifier) was first discovered to be a synergistic signal that is activated following IL-17A and IL-6 stimulation in type 1 collagen+ non-immune cells. Subsequent disease models have shown that it can also be stimulated by the simultaneous activation of NFκB and STAT3, functions as a local chemokine inducer, and acts as a mechanism for local inflammation, particularly chronic ones like rheumatoid arthritis and a multiple sclerosis. Moreover, we have recently shown that hyper activation of the IL-6 amplifier via regional neural activation establishes a gateway for immune cells including autoreactive T cells to pass the blood-brain barrier at dorsal vessels in 5(th) lumbar cord. Here we review how the IL-6 amplifier is activated by neural activation and the physiological relevance of the gateway to the central nervous system. Accumulating evidences continues to suggest that the IL-6 amplifier offers a potential molecular mechanism for the relationship between neural activation and the development of inflammatory diseases, which could establish a new interdisciplinary field that fuses neurology and immunology.

Citing Articles

Identification of Shared Signature Genes and Immune Microenvironment Subtypes for Heart Failure and Chronic Kidney Disease Based on Machine Learning.

Wang X, Rao J, Chen X, Wang Z, Zhang Y J Inflamm Res. 2024; 17:1873-1895.

PMID: 38533476 PMC: 10964169. DOI: 10.2147/JIR.S450736.

Leveraging Structured Biological Knowledge for Counterfactual Inference: A Case Study of Viral Pathogenesis.

Zucker J, Paneri K, Mohammad-Taheri S, Bhargava S, Kolambkar P, Bakker C IEEE Trans Big Data. 2023; 7(1):25-37.

PMID: 37981991 PMC: 8769018. DOI: 10.1109/TBDATA.2021.3050680.

The regulation of lncRNAs and miRNAs in SARS-CoV-2 infection.

Lin Y, Sun Q, Zhang B, Zhao W, Shen C Front Cell Dev Biol. 2023; 11:1229393.

PMID: 37576600 PMC: 10416254. DOI: 10.3389/fcell.2023.1229393.

Transplantation of Umbilical Cord-Derived Mesenchymal Stem Cells Attenuates Surgical Wound-Induced Blood-Brain Barrier Dysfunction in Mice.

Yang J, Li H, Ran M, Yang S, Ma K, Zhang C Stem Cells Int. 2023; 2023:8667045.

PMID: 36895785 PMC: 9991482. DOI: 10.1155/2023/8667045.

New insight into neurological degeneration: Inflammatory cytokines and blood-brain barrier.

Yang J, Ran M, Li H, Lin Y, Ma K, Yang Y Front Mol Neurosci. 2022; 15:1013933.

PMID: 36353359 PMC: 9637688. DOI: 10.3389/fnmol.2022.1013933.

References

Tanaka T, Kishimoto T . Immunotherapeutic implication of IL-6 blockade. Immunotherapy. 2011; 4(1):87-105. DOI: 10.2217/imt.11.147. View

Hendrik Niess J, Brand S, Xiubin Gu , Landsman L, Jung S, McCormick B . CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science. 2005; 307(5707):254-8. DOI: 10.1126/science.1102901. View

Fukada T, Hibi M, Yamanaka Y, Fujitani Y, Yamaguchi T, Nakajima K . Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity. 1996; 5(5):449-60. DOI: 10.1016/s1074-7613(00)80501-4. View

Wilson E, Weninger W, Hunter C . Trafficking of immune cells in the central nervous system. J Clin Invest. 2010; 120(5):1368-79. PMC: 2860945. DOI: 10.1172/JCI41911. View

Sawa S, Kamimura D, Jin G, Morikawa H, Kamon H, Nishihara M . Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells. J Exp Med. 2006; 203(6):1459-70. PMC: 2118324. DOI: 10.1084/jem.20052187. View

Ogura H, Murakami M, Okuyama Y, Tsuruoka M, Kitabayashi C, Kanamoto M . Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity. 2008; 29(4):628-36. DOI: 10.1016/j.immuni.2008.07.018. View

Lee J, Nakagiri T, Oto T, Harada M, Morii E, Shintani Y . IL-6 amplifier, NF-κB-triggered positive feedback for IL-6 signaling, in grafts is involved in allogeneic rejection responses. J Immunol. 2012; 189(4):1928-36. DOI: 10.4049/jimmunol.1103613. View

Park S, Nakagawa T, Kitamura H, Atsumi T, Kamon H, Sawa S . IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J Immunol. 2004; 173(6):3844-54. DOI: 10.4049/jimmunol.173.6.3844. View

Kaplanski G, Teysseire N, Farnarier C, Kaplanski S, Lissitzky J, Durand J . IL-6 and IL-8 production from cultured human endothelial cells stimulated by infection with Rickettsia conorii via a cell-associated IL-1 alpha-dependent pathway. J Clin Invest. 1995; 96(6):2839-44. PMC: 185994. DOI: 10.1172/JCI118354. View

10.

Salinas S, Schiavo G, Kremer E . A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins. Nat Rev Microbiol. 2010; 8(9):645-55. DOI: 10.1038/nrmicro2395. View

11.

Sakaguchi S, Sakaguchi N . Animal models of arthritis caused by systemic alteration of the immune system. Curr Opin Immunol. 2005; 17(6):589-94. DOI: 10.1016/j.coi.2005.09.017. View

12.

Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B . Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol. 1988; 18(11):1797-801. DOI: 10.1002/eji.1830181122. View

13.

Bettelli E, Carrier Y, Gao W, Korn T, Strom T, Oukka M . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. DOI: 10.1038/nature04753. View

14.

Veldhoen M, Hocking R, Atkins C, Locksley R, Stockinger B . TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006; 24(2):179-89. DOI: 10.1016/j.immuni.2006.01.001. View

15.

Murakami M, Okuyama Y, Ogura H, Asano S, Arima Y, Tsuruoka M . Local microbleeding facilitates IL-6- and IL-17-dependent arthritis in the absence of tissue antigen recognition by activated T cells. J Exp Med. 2011; 208(1):103-14. PMC: 3023133. DOI: 10.1084/jem.20100900. View

16.

Nakagawa T, Tsuruoka M, Ogura H, Okuyama Y, Arima Y, Hirano T . IL-6 positively regulates Foxp3+CD8+ T cells in vivo. Int Immunol. 2010; 22(2):129-39. DOI: 10.1093/intimm/dxp119. View

17.

Arima Y, Harada M, Kamimura D, Park J, Kawano F, Yull F . Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell. 2012; 148(3):447-57. DOI: 10.1016/j.cell.2012.01.022. View

18.

Hirano T . Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir. Proc Jpn Acad Ser B Phys Biol Sci. 2010; 86(7):717-30. PMC: 3066534. DOI: 10.2183/pjab.86.717. View

19.

Hirano T . Interleukin 6 and its receptor: ten years later. Int Rev Immunol. 1998; 16(3-4):249-84. DOI: 10.3109/08830189809042997. View

20.

Suthaus J, Tillmann A, Lorenzen I, Bulanova E, Rose-John S, Scheller J . Forced homo- and heterodimerization of all gp130-type receptor complexes leads to constitutive ligand-independent signaling and cytokine-independent growth. Mol Biol Cell. 2010; 21(15):2797-807. PMC: 2912364. DOI: 10.1091/mbc.E10-03-0240. View